• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Dr. Schachat joins Cole Eye Insitute

Article

Cleveland-Andrew P. Schachat, MD, joins the Cleveland Clinic Foundation's Cole Eye Institute as vice chairman for clinical affairs for the division of ophthalmology. He will focus on clinical affairs and their contribution to the overall success of the Cole Eye Institute program.

"We are thrilled to have recruited such a pre-eminent ophthalmologist to join our staff," said Hilel Lewis, MD, chairman of the Cole Eye Institute.

"He will provide valuable guidance to help the clinical staff achieve even greater success and will be an excellent addition to our retina services," Dr. Hilel added.

"I enjoy helping others succeed and look forward to working on behalf of the Cole Eye Institute and Cleveland Clinic," Dr. Schachat said. "I'm honored to join the talented team of individuals at the Cole Eye Institute, who under the leadership of Dr. Lewis have enjoyed many achievements."

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.